Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Immuron Ltd changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 7 | 6 | −1 |
| Shares | 84.9K | 78.3K | −6.52K (−7.7%) |
| Value | $65.7K | $82.2K | +$16.5K (+25.0%) |
New holders (2)
Institutions that held Immuron Ltd at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 20,584 | $21.0K | 0.00% |
| UBS Group AG | 363 | $385 | 0.00% |
Sold out (3)
Institutions that held Immuron Ltd at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| XTX Topco Ltd | 17,383 | $13.5K |
| Two Sigma Securities, LLC | 10,906 | $8.45K |
| BlackRock, Inc. | 225 | $174 |